-
1
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
-
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375.
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
-
2
-
-
0028921708
-
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
-
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG, (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155: 469-473.
-
(1995)
Arch Intern Med
, vol.155
, pp. 469-473
-
-
Feinberg, W.M.1
Blackshear, J.L.2
Laupacis, A.3
Kronmal, R.4
Hart, R.G.5
-
3
-
-
79952770422
-
Lone atrial fibrillation: what is known and what is to come
-
Potpara TS, Lip GY, (2011) Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 65: 446-457.
-
(2011)
Int J Clin Pract
, vol.65
, pp. 446-457
-
-
Potpara, T.S.1
Lip, G.Y.2
-
4
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
-
Wolf PA, Abbott RD, Kannel WB, (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22: 983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
5
-
-
33645501775
-
Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond
-
Boger RH, (2006) Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38: 126-136.
-
(2006)
Ann Med
, vol.38
, pp. 126-136
-
-
Boger, R.H.1
-
6
-
-
77951642455
-
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
-
Sibal L, Agarwal SC, Home PD, Boger RH, (2010) The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev 6: 82-90.
-
(2010)
Curr Cardiol Rev
, vol.6
, pp. 82-90
-
-
Sibal, L.1
Agarwal, S.C.2
Home, P.D.3
Boger, R.H.4
-
7
-
-
27744511357
-
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study
-
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, et al. (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97: e53-59.
-
(2005)
Circ Res
, vol.97
-
-
Schnabel, R.1
Blankenberg, S.2
Lubos, E.3
Lackner, K.J.4
Rupprecht, H.J.5
-
8
-
-
79960300381
-
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease
-
Lu TM, Chung MY, Lin CC, Hsu CP, Lin SJ, (2011) Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease. Clin J Am Soc Nephrol 6: 1566-1572.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 1566-1572
-
-
Lu, T.M.1
Chung, M.Y.2
Lin, C.C.3
Hsu, C.P.4
Lin, S.J.5
-
9
-
-
74749108725
-
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
-
Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, et al. (2010) Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 208: 518-523.
-
(2010)
Atherosclerosis
, vol.208
, pp. 518-523
-
-
Schulze, F.1
Carter, A.M.2
Schwedhelm, E.3
Ajjan, R.4
Maas, R.5
-
10
-
-
39349085786
-
Asymmetrical dimethylarginine level in atrial fibrillation
-
Cengel A, Sahinarslan A, Biberoglu G, Hasanoglu A, Tavil Y, et al. (2008) Asymmetrical dimethylarginine level in atrial fibrillation. Acta Cardiol 63: 33-37.
-
(2008)
Acta Cardiol
, vol.63
, pp. 33-37
-
-
Cengel, A.1
Sahinarslan, A.2
Biberoglu, G.3
Hasanoglu, A.4
Tavil, Y.5
-
11
-
-
84855831160
-
The impact of rapid atrial pacing on ADMA and endothelial NOS
-
Goette A, Hammwohner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, et al. (2012) The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol 154: 141-146.
-
(2012)
Int J Cardiol
, vol.154
, pp. 141-146
-
-
Goette, A.1
Hammwohner, M.2
Bukowska, A.3
Scalera, F.4
Martens-Lobenhoffer, J.5
-
12
-
-
70449705942
-
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion
-
Xia W, Yin Z, Li J, Song Y, Qu X, (2009) Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing Clin Electrophysiol 32: 1562-1566.
-
(2009)
Pacing Clin Electrophysiol
, vol.32
, pp. 1562-1566
-
-
Xia, W.1
Yin, Z.2
Li, J.3
Song, Y.4
Qu, X.5
-
13
-
-
84855658119
-
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation
-
Yang L, Xiufen Q, Shuqin S, Yang Y, Ying S, et al. (2011) Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 32: 147-154.
-
(2011)
J Interv Card Electrophysiol
, vol.32
, pp. 147-154
-
-
Yang, L.1
Xiufen, Q.2
Shuqin, S.3
Yang, Y.4
Ying, S.5
-
14
-
-
34249814933
-
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
-
Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, et al. (2007) HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4: 816-861.
-
(2007)
Heart Rhythm
, vol.4
, pp. 816-861
-
-
Calkins, H.1
Brugada, J.2
Packer, D.L.3
Cappato, R.4
Chen, S.A.5
-
15
-
-
77957699729
-
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
-
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: 2369-2429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
-
16
-
-
76749163232
-
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
-
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137: 263-272.
-
(2010)
Chest
, vol.137
, pp. 263-272
-
-
Lip, G.Y.1
Nieuwlaat, R.2
Pisters, R.3
Lane, D.A.4
Crijns, H.J.5
-
17
-
-
0142209281
-
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
-
Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC, (2003) Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24: 1912-1919.
-
(2003)
Eur Heart J
, vol.24
, pp. 1912-1919
-
-
Lu, T.M.1
Ding, Y.A.2
Lin, S.J.3
Lee, W.S.4
Tai, H.C.5
-
18
-
-
56049112978
-
Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs
-
Liu H, Qu X, Liang Z, Chen W, Xia W, et al. (2008) Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. Biochem Biophys Res Commun 377: 884-888.
-
(2008)
Biochem Biophys Res Commun
, vol.377
, pp. 884-888
-
-
Liu, H.1
Qu, X.2
Liang, Z.3
Chen, W.4
Xia, W.5
-
19
-
-
31844444125
-
Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells
-
Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, et al. (2006) Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 44: 143-148.
-
(2006)
Vascul Pharmacol
, vol.44
, pp. 143-148
-
-
Jia, S.J.1
Jiang, D.J.2
Hu, C.P.3
Zhang, X.H.4
Deng, H.W.5
-
20
-
-
83455230998
-
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase
-
von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, et al. (2011) Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation 124: 2735-2745.
-
(2011)
Circulation
, vol.124
, pp. 2735-2745
-
-
von Leitner, E.C.1
Klinke, A.2
Atzler, D.3
Slocum, J.L.4
Lund, N.5
-
21
-
-
48249093448
-
Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion
-
Xia W, Qu X, Yu Y, Zhang X, Feng W, et al. (2008) Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. Pacing Clin Electrophysiol 31: 1036-1040.
-
(2008)
Pacing Clin Electrophysiol
, vol.31
, pp. 1036-1040
-
-
Xia, W.1
Qu, X.2
Yu, Y.3
Zhang, X.4
Feng, W.5
-
22
-
-
79958796133
-
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients
-
Roldan V, Marin F, Muina B, Torregrosa JM, Hernandez-Romero D, et al. (2011) Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 57: 2496-2504.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 2496-2504
-
-
Roldan, V.1
Marin, F.2
Muina, B.3
Torregrosa, J.M.4
Hernandez-Romero, D.5
-
23
-
-
84865258462
-
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
-
Roldan V, Marin F, Diaz J, Gallego P, Jover E, et al. (2012) High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost 10: 1500-1507.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1500-1507
-
-
Roldan, V.1
Marin, F.2
Diaz, J.3
Gallego, P.4
Jover, E.5
-
24
-
-
33644559016
-
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
-
Wanby P, Teerlink T, Brudin L, Brattstrom L, Nilsson I, et al. (2006) Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis 185: 271-277.
-
(2006)
Atherosclerosis
, vol.185
, pp. 271-277
-
-
Wanby, P.1
Teerlink, T.2
Brudin, L.3
Brattstrom, L.4
Nilsson, I.5
-
25
-
-
0842347848
-
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
-
Boger RH, (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59: 824-833.
-
(2003)
Cardiovasc Res
, vol.59
, pp. 824-833
-
-
Boger, R.H.1
-
26
-
-
0028085059
-
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
-
van der Wal AC, Becker AE, van der Loos CM, Das PK, (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44.
-
(1994)
Circulation
, vol.89
, pp. 36-44
-
-
van der Wal, A.C.1
Becker, A.E.2
van der Loos, C.M.3
Das, P.K.4
-
27
-
-
0041733065
-
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
-
Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, et al. (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455-1459.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1455-1459
-
-
Achan, V.1
Broadhead, M.2
Malaki, M.3
Whitley, G.4
Leiper, J.5
-
28
-
-
33747186695
-
ADMA increases arterial stiffness and decreases cerebral blood flow in humans
-
Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, et al. (2006) ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37: 2024-2029.
-
(2006)
Stroke
, vol.37
, pp. 2024-2029
-
-
Kielstein, J.T.1
Donnerstag, F.2
Gasper, S.3
Menne, J.4
Kielstein, A.5
-
29
-
-
77953682224
-
Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox
-
Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, et al. (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123: 646-651.
-
(2010)
Am J Med
, vol.123
, pp. 646-651
-
-
Badheka, A.O.1
Rathod, A.2
Kizilbash, M.A.3
Garg, N.4
Mohamad, T.5
-
30
-
-
77955465471
-
Obesity and outcomes among patients with established atrial fibrillation
-
Ardestani A, Hoffman HJ, Cooper HA, (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106: 369-373.
-
(2010)
Am J Cardiol
, vol.106
, pp. 369-373
-
-
Ardestani, A.1
Hoffman, H.J.2
Cooper, H.A.3
-
31
-
-
77953851760
-
Underuse of oral anticoagulants in atrial fibrillation: a systematic review
-
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123: 638-645 e634.
-
(2010)
Am J Med
, vol.123
-
-
Ogilvie, I.M.1
Newton, N.2
Welner, S.A.3
Cowell, W.4
Lip, G.Y.5
-
32
-
-
80053992926
-
Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program)
-
Chan PS, Maddox TM, Tang F, Spinler S, Spertus JA, (2011) Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program). Am J Cardiol 108: 1136-1140.
-
(2011)
Am J Cardiol
, vol.108
, pp. 1136-1140
-
-
Chan, P.S.1
Maddox, T.M.2
Tang, F.3
Spinler, S.4
Spertus, J.A.5
-
33
-
-
78650951581
-
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice
-
Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY, (2011) A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 9: 39-48.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 39-48
-
-
Van Staa, T.P.1
Setakis, E.2
Di Tanna, G.L.3
Lane, D.A.4
Lip, G.Y.5
-
34
-
-
84861725443
-
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
-
Friberg L, Rosenqvist M, Lip GY, (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 33: 1500-1510.
-
(2012)
Eur Heart J
, vol.33
, pp. 1500-1510
-
-
Friberg, L.1
Rosenqvist, M.2
Lip, G.Y.3
-
35
-
-
84868523625
-
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
-
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, et al. (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33: 2719-2747.
-
(2012)
Eur Heart J
, vol.33
, pp. 2719-2747
-
-
Camm, A.J.1
Lip, G.Y.2
De Caterina, R.3
Savelieva, I.4
Atar, D.5
|